STAT3 and hepatocellular carcinoma: Additionally, STAT3 signaling, crucial for tumor malignancy,[34, 35, 36] was markedly activated in hepatoma cells exposed to N‐CM, minimally impacted by sorafenib treatment (Figure 6D).